微流體免疫檢測市場規模、佔有率、成長分析，按產品、技術、應用、最終用戶、地區分類 - 產業預測，2025 年至 2032 年

2023 年全球微流體免疫檢測市場規模為 12 億美元，預計將從 2024 年的 12.9 億美元成長到 2032 年的 23.6 億美元，預測期內（2025-2032 年）的複合年成長率為 7.8%。

微流體免疫檢測市場正在經歷快速成長，這得益於對具有成本效益、高照護現場診斷（POC）的需求不斷成長，尤其是在資源有限的環境中。受人口變化和重症監護快速決策需求的推動，POC 測試在醫院、診所甚至家庭測試中變得越來越普遍。儘管目前存在諸如需要製備樣品以及與現有儀器的結果不一致等挑戰，但人們對能夠以最少的試劑使用提供準確和定量結果的實驗室晶片(LOC) 技術的興趣日益濃厚。這一趨勢受到大量創業投資投資、微流體技術的持續研究以及老齡化社會中慢性病日益流行的推動，使得 LOC 成為免疫診斷領域的遊戲規則改變者。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究分析

微流體免疫檢測市場規模（依產品）

• 市場概況
• 耗材
• 墨水匣
• 聚合物
• 玻璃
• 矽
• 試劑
• 系統

微流體免疫檢測市場規模（依技術）

• 市場概況
• 電化學檢測
• 光學檢測

微流體免疫檢測市場規模（依應用）

• 市場概況
• 心臟病學
• 單一生物標記檢測
• 多重生物標記檢測
• 感染疾病
• 腫瘤學
• 其他用途

微流體免疫檢測市場規模（按最終用戶分類）

• 市場概況
• 製藥和生物技術公司
• 診斷實驗室
• 醫院
• 其他最終用戶

微流體免疫檢測市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Abbott Laboratories（US）
• Bio-Rad Laboratories（US）
• Becton, Dickinson and Company（US）
• Danaher Corporation（US）
• Fluidigm Corporation（US）
• GE Healthcare（US）
• Illumina Inc.（US）
• Luminex Corporation（US）
• Merck Millipore（Germany）
• PerkinElmer Inc.（US）
• Randox Laboratories Ltd.（UK）
• Roche Diagnostics（Switzerland）
• Siemens Healthineers AG（Germany）
• Thermo Fisher Scientific Inc.（US）
• Tosoh Corporation（Japan）
• Wako Pure Chemical Industries, Ltd.（Japan）
• Waters Corporation（US）

結論和建議

Global Microfluidic Immunoassay Market size was valued at USD 1.2 billion in 2023 and is poised to grow from USD 1.29 billion in 2024 to USD 2.36 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The microfluidic immunoassay market is experiencing rapid growth, driven by the increasing demand for cost-effective, high-throughput point-of-care (POC) diagnostics, especially in resource-limited settings. POC tests are becoming more prevalent in hospitals, clinics, and even at-home testing, spurred by demographic changes and the need for faster decision-making in emergency care. Despite current challenges, such as the need for sample pre-treatment and inconsistent results from existing devices, there is rising interest in lab-on-a-chip (LOC) technology, which offers precise, quantitative results with minimal reagent use. This trend is bolstered by substantial venture capital investments, ongoing research in microfluidic technology, and the growing prevalence of chronic diseases among an aging population, positioning LOC as a game-changer in immunodiagnostics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microfluidic Immunoassay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microfluidic Immunoassay Market Segmental Analysis

Global Microfluidic Immunoassay Market is segmented by Product, Technology, Application, End User and region. Based on Product, the market is segmented into Consumables, Cartridges, Polymer, Glass, Silicon, Reagents and Systems. Based on Technology, the market is segmented into Electrochemical Detection and Optical Detection. Based on Application, the market is segmented into Cardiology, Single Biomarker Detection, Multiplexed Biomarker Detection, Infectious Diseases, Oncology and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Hospital and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microfluidic Immunoassay Market

The microfluidic immunoassay market is poised for significant growth driven by the advent of innovative technologies and the potential of emerging economies. The introduction of novel advancements, such as paper-based microfluidics, is expected to unlock numerous growth opportunities for industry players. Boosted by factors like an aging population, a large patient base with infectious and non-communicable diseases, increased funding for research and development, and a heightened demand for quality healthcare services, these economies are witnessing substantial progress. Furthermore, rising disposable incomes and enhanced healthcare infrastructure are contributing to the market's expansion, creating an optimistic outlook for the sector.

Restraints in the Global Microfluidic Immunoassay Market

The Global Microfluidic Immunoassay market faces various restraints that could impede its growth, particularly in developing nations. Key challenges include the difficulty in selecting appropriate substrate materials for microfluidic chip fabrication, securing reimbursement for these technologies, and scaling up production for widespread availability. Additionally, the lack of affordable options poses a significant barrier, as low-cost products are essential for adoption in underdeveloped regions. These issues contribute to limited accessibility and availability, ultimately hindering the overall market potential in countries where healthcare resources are constrained. Addressing these challenges will be crucial for the market's expansion.

Market Trends of the Global Microfluidic Immunoassay Market

The Global Microfluidic Immunoassay market is witnessing a significant upward trend, driven by the increasing adoption of lab-on-a-chip (LOC) technologies that streamline diagnostic processes by integrating multiple laboratory functions onto a compact platform. This shift eliminates the necessity for cumbersome equipment, enhancing accessibility and efficiency, particularly in point-of-care (POC) settings. Furthermore, the popularity of paper-based microfluidics is rising, especially in developing regions, due to its cost-effectiveness, versatility, and reliance on capillary action for fluid management. With extensive commercial and academic research advancing this field, the market is poised for substantial growth as it increasingly supports rapid diagnostics and personalized medicine.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global Microfluidic Immunoassay Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables
• Cartridges
• Polymer
• Glass
• Silicon
• Reagents
• Systems

Global Microfluidic Immunoassay Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Electrochemical Detection
• Optical Detection

Global Microfluidic Immunoassay Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cardiology
• Single Biomarker Detection
• Multiplexed Biomarker Detection
• Infectious Diseases
• Oncology
• Other Applications

Global Microfluidic Immunoassay Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Diagnostic Laboratories
• Hospital
• Other End Users

Global Microfluidic Immunoassay Market Size & CAGR (2025-2032)

• North America (Product, Technology, Application, End User)
  • US
  • Canada
• Europe (Product, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Millipore (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tosoh Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wako Pure Chemical Industries, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations